Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

cbdMD (YCBD) Return on Equity (2017 - 2025)

Historic Return on Equity for cbdMD (YCBD) over the last 9 years, with Q3 2025 value amounting to 0.31%.

  • cbdMD's Return on Equity rose 11800.0% to 0.31% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.31%, marking a year-over-year increase of 11800.0%. This contributed to the annual value of 0.44% for FY2025, which is 2300.0% up from last year.
  • According to the latest figures from Q3 2025, cbdMD's Return on Equity is 0.31%, which was up 11800.0% from 0.45% recorded in Q2 2025.
  • Over the past 5 years, cbdMD's Return on Equity peaked at 0.0% during Q1 2021, and registered a low of 6.35% during Q2 2024.
  • Its 5-year average for Return on Equity is 1.54%, with a median of 1.32% in 2023.
  • Its Return on Equity has fluctuated over the past 5 years, first tumbled by -55100bps in 2024, then soared by 59100bps in 2025.
  • Over the past 5 years, cbdMD's Return on Equity (Quarter) stood at 0.2% in 2021, then crashed by -826bps to 1.89% in 2022, then tumbled by -31bps to 2.49% in 2023, then soared by 42bps to 1.44% in 2024, then soared by 79bps to 0.31% in 2025.
  • Its Return on Equity was 0.31% in Q3 2025, compared to 0.45% in Q2 2025 and 0.13% in Q1 2025.